Gilead signs Voluntary Licensing Agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan for remdesivir Read more
While the market is bleeding, pharma sector has withstood the lock-down. Can it be a good bet for investors? Read more
Cipla announces completion of phase-3 clinical study for generic version of GSK’s Advair Diskus Read more
Cipla receives final approval for generic version of AstraZeneca Pharmaceutical’s Nexium (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg) Read more